mTORC1 links pathology in experimental models of Still’s disease and macrophage activation syndrome
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
mTORC1 links pathology in experimental models of Still’s disease and macrophage activation syndrome
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-11-28
DOI
10.1038/s41467-022-34480-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum proteome analysis of systemic JIA and related lung disease identifies distinct inflammatory programs and biomarkers
- (2022) Guangbo Chen et al. Arthritis & Rheumatology
- ‘SMASH’ recommendations for standardised microscopic arthritis scoring of histological sections from inflammatory arthritis animal models
- (2021) Silvia Hayer et al. ANNALS OF THE RHEUMATIC DISEASES
- Immune cartography of macrophage activation syndrome in the COVID-19 era
- (2021) Dennis McGonagle et al. Nature Reviews Rheumatology
- Refractory systemic juvenile idiopathic arthritis successfully treated with rapamycin
- (2021) Sara Concha et al. RHEUMATOLOGY
- Integrated analysis of multimodal single-cell data
- (2021) Yuhan Hao et al. CELL
- Author Correction: mTOR at the nexus of nutrition, growth, ageing and disease
- (2020) Grace Y. Liu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Increased mTOR activation in idiopathic multicentric Castleman disease
- (2020) Daniel J. Arenas et al. BLOOD
- Chronic TLR7 and TLR9 signaling drives anemia via differentiation of specialized hemophagocytes
- (2019) Holly M. Akilesh et al. SCIENCE
- Specific sequences of infectious challenge lead to secondary hemophagocytic lymphohistiocytosis-like disease in mice
- (2019) Andrew Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Megakaryocyte emperipolesis mediates membrane transfer from intracytoplasmic neutrophils to platelets
- (2019) Pierre Cunin et al. eLife
- Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases
- (2019) Adriana A. de Jesus et al. JOURNAL OF CLINICAL INVESTIGATION
- Hemophagocytic Lymphohistiocytosis
- (2018) Hanny Al-Samkari et al. Annual Review of Pathology-Mechanisms of Disease
- Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome
- (2018) Eric S. Weiss et al. BLOOD
- Development of a Validated Interferon Score Using NanoString Technology
- (2018) Hanna Kim et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial
- (2018) Zhi-Wei Lai et al. LANCET
- Massively parallel digital transcriptional profiling of single cells
- (2017) Grace X. Y. Zheng et al. Nature Communications
- Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
- (2016) Claudia Bracaglia et al. ANNALS OF THE RHEUMATIC DISEASES
- Mortality rates are increased in patients with systemic juvenile idiopathic arthritis
- (2016) Rebecca Davies et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Complex heatmaps reveal patterns and correlations in multidimensional genomic data
- (2016) Zuguang Gu et al. BIOINFORMATICS
- Macrophage activation syndrome in the era of biologic therapy
- (2016) Alexei A. Grom et al. Nature Reviews Rheumatology
- Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies
- (2016) D. M. Adams et al. PEDIATRICS
- 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborat
- (2016) Angelo Ravelli et al. Arthritis & Rheumatology
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- IL-1 receptor antagonist-deficient mice develop autoimmune arthritis due to intrinsic activation of IL-17-producing CCR2+Vγ6+γδ T cells
- (2015) Aoi Akitsu et al. Nature Communications
- Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab
- (2015) Alexei A. Grom et al. Arthritis & Rheumatology
- The Molecular Signatures Database Hallmark Gene Set Collection
- (2015) Arthur Liberzon et al. Cell Systems
- Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients
- (2014) Francesca Minoia et al. Arthritis & Rheumatology
- Whole-Exome Sequencing Reveals Overlap Between Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis and Familial Hemophagocytic Lymphohistiocytosis
- (2014) Kenneth M. Kaufman et al. Arthritis & Rheumatology
- Review: Is There a Window of Opportunity for Treatment of Systemic Juvenile Idiopathic Arthritis?
- (2014) Peter A. Nigrovic Arthritis & Rheumatology
- Clinical Everolimus Experience in Pediatric Renal Transplant Patients
- (2013) N. Dincel et al. TRANSPLANTATION PROCEEDINGS
- Ly6G ligation blocks recruitment of neutrophils via a 2-integrin-dependent mechanism
- (2012) J.-X. Wang et al. BLOOD
- Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment
- (2012) A Ravelli et al. GENES AND IMMUNITY
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Nicolino Ruperto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Repeated TLR9 stimulation results in macrophage activation syndrome–like disease in mice
- (2011) Edward M. Behrens et al. JOURNAL OF CLINICAL INVESTIGATION
- Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions
- (2011) Elizabeth D. Mellins et al. Nature Reviews Rheumatology
- Rapamycin does not control hemophagocytic lymphohistiocytosis in LCMV-infected perforin-deficient mice
- (2011) Jennifer A. Rothman et al. PEDIATRIC BLOOD & CANCER
- Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth
- (2011) Q. Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
- (2010) P. Quartier et al. ANNALS OF THE RHEUMATIC DISEASES
- Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: Report of forty-six patients from an international multicenter series
- (2010) Peter A. Nigrovic et al. ARTHRITIS AND RHEUMATISM
- The Mammalian Target of Rapamycin: Linking T Cell Differentiation, Function, and Metabolism
- (2010) Jonathan D. Powell et al. IMMUNITY
- Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states
- (2009) Claudia Macaubas et al. CLINICAL IMMUNOLOGY
- Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study
- (2007) G A W Bruyn et al. ANNALS OF THE RHEUMATIC DISEASES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now